The Brien Holden Vision Institute is a multidisciplinary research organisation dedicated to achieving vision excellence for all people. Based in Sydney, Australia, the Institute aims to deliver vision correction solutions to eye conditions affecting billions worldwide by collaborating with the best research and industry organisations. It is now seeking to also apply its vision research more broadly - in new materials to fight infection and alternative ways to diagnose disease
The Brien Holden Vision Institute is an Accredited Independent Research Institute with the National Health and Medical Research Council (NHMRC) and a member of the Association of Australian Medical Research Institutes (AAMRI). It possesses a multidisciplinary team - combining expertise in clinical trials research, biological sciences research and technology development - which provides the capacity to convert revolutionary ideas into major advances in eye health and vision correction technologies.
With its research and industry partners the Institute has delivered a series of succesful commercial products, including:
- The silicone hydrogel contact lens, first commercialised as the Focus Night & DayTM contact lens by CIBA VISION. This lens material now accounts for more than 50 % of the contact lens market in the US.
- Soft toric contact lenses for the correction of astigmatism, launched worldwide as the Biomedics Toric lens in 2002.
- Multifocal soft contact lens for correction of presbyopia launched by CIBA VISION in 2009 as the AIR OPTIXTM AQUA MULTIFOCAL contact lenses.
- In 2010, the MyoVisionTM spectacle lens was released by industry partner Carl Zeiss Vision. The spectacle has demonstrated an ability to slow the rate of progress of myopia by 30% in children six to 12 years of age, where the child has a certain history of parental myopia.
The royalty stream generated from this commercial success enables the Institute to reinvest in further breakthrough research, as well as education and humanitarian programs.
The Brien Holden Vision Institute hosts the Vision CRC secretariat and provides the operational leadership for Vision CRC at its offices in Sydney. The Institute also provides its clinical research, biological sciences and technology facilities and expertise, along with administrative support for Vision CRC.
The Institute is an essential participant in Vision CRC and participates in the Biomaterials, Ocular Comfort and Myopia Control Programs.
To visit the Brien Holden Vision Institute website go to: www.brienholdenvision.org
